key: cord-0749401-eqma5xst
authors: Einstein, Andrew J.; Vitola, Joao V.; Williams, Michelle C.; Shaw, Leslee J.; Paez, Diana
title: Reply: Collateral Casualties of COVID-19
date: 2021-05-25
journal: J Am Coll Cardiol
DOI: 10.1016/j.jacc.2021.03.308
sha: 9ba1ab3469eabe43be9e859bde26634161547ba8
doc_id: 749401
cord_uid: eqma5xst

nan

units in the Netherlands (2) . In a country proud of its national screening program, Latinga et al. (2) found that gastroscopies decreased by a staggering 57% and colonoscopies by 45%, with a subsequent reduction in the number of gastrointestinal cancers detected. Similar disappointing results were seen in a national study in the United Kingdom (3) . Early in the United Kingdom's response to the pandemic, endoscopy activity reduced to just 5% of normal activity, and 10 weeks later activity had increased to only 20% of pre-pandemic levels. Dr. A. Koulaouzidis is codirector of iCERV and cofounder of AJM Medicaps; has received honoraria from Dr. Falk Pharma UK, and Jinshan; has received travel support from Jinshan, Dr. Falk (UK), and Aquilant; has been in advisory board meetings for Tilots, Dr. Falk Pharma (UK), and Ankon; and has served as a consultant for Jinshan. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Kim A. Eagle, MD, served as Guest Associate Editor for this paper. Athena Poppas, MD, served as Guest Editor-in-Chief for this paper. The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors' institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center. aggressively address these challenges to minimize the long-term burden of the pandemic.

International impact of COVID-19 on the diagnosis of heart disease

The impact of the COVID-19 pandemic on breast imaging

COVID-19 and cancer

The landscape of cardiovascular clinical trials in the United States initiated before and during COVID-19

The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors' institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center.